Monday, September 11, 2023 Daily Archives

TherageniX and UK Uni team to develop powdered gene therapy

by

Innovate UK has awarded TherageniX and the University of Nottingham $1.2 million to develop a powder non-viral gene delivery system for bone regeneration. TherageniX, a spin-out from the University of Nottingham, is developing a dry powder gene therapy formulation that aims to be used for bone graft augmentation. Innovate UK has provided TherageniX and its collaborator, the University of Nottingham, with a £995,000 ($1.2 million) grant. The funding will support the development of the gene delivery system to improve the…

GSK batting strong in ‘newly democratized’ vaccines space

by

Not being reliant on a single platform is an advantage in a vaccine industry where traditional barriers to entry have been broken by the advent of mRNA, says GSK. Historically, the vaccine space more than any other modality has struggled with manufacturing inflexibility and expensive entry requirements. A few years ago, the market was controlled by just four companies – GSK, Sanofi, Merck & Co., Pfizer – which generated nearly 90% of total vaccine revenue. But COVID-19 efforts brought about…

Female funding issues: ATE channels its biotech Barbie

by

The Barbie Movie phenomenon entered the biotech world as attendees at Advanced Therapies Europe gathered in Lisbon, Portugal to discuss why women often ask for less in a business setting.   While the topic of Barbie does not often arise in a conference setting, Becky Kent, head of Women in Advanced Therapies (WIAT) at Phacilitate, kicked off the pre-day session with the following quote from the recent blockbuster movie:  “It is literally impossible to be a woman. You are so beautiful,…

September 11, 2023